Get started
Hims & Hers Health, Inc. Class AHims & Hers Health, Inc. Class AHims & Hers Health, Inc. Class A

Hims & Hers Health, Inc. Class A

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsBondsETFs

Trade ideas

HIMS: Showing Signs of Exhaustion: Downside Targets at 42 and 33HIMS: Showing Signs of Exhaustion: Downside Targets at 42 and 33 HIMS appears to be forming a rising wedge pattern, a typically bearish formation that often signals exhaustion of upward momentum. After several failed attempts to break higher, the price has now started to pull back, suggesting that sellers are regaining control. A possible correction near to 52.30 can happen before it moves down further HIMS could continue falling toward its first target at 42.00 A deeper correction could then extend toward the second target around 33.00, completing the bearish move. You may find more details in the chart! Thank you and Good Luck! ❤️PS: Please support with a like or comment if you find this analysis useful for your trading day❤️
NYSE:HIMSShort
by KlejdiCuni
6
HIMS rebounding from 200-day SMA to $60 by end of Nov?HIMS is having a mean reversion back to the 200-day SMA (red line). Last 3 times it touched it, it rebounded at least 30% the month after. It might take a week or two to form the short term bottom. The blue MACD line seems to be flattening out. Last few times it happens, stock rebounded. When the blue MACD line flattens out and then crosses upward through the red Signal line, it signals that downward momentum is weakening and bullish momentum may be starting. This is a Bullish Crossover → buy signal.
NYSE:HIMSLong
by tin921
HIMS - Stay above $46?Uptrend line: The long-term weekly trendline from mid-2023 is intact, but the price is sitting right on it now. A weekly close below ~$46 would technically break that trend. Volume profile: Most of the volume sits in the $44–$48 range — this zone is key support. If it holds, you can expect a bounce; if it fails, the next strong node is around $38–$40. RSI: Neutral at ~48 — not oversold, not overbought. Momentum could swing either direction. Resistance: Heavy around $52–$54 (the red line you drew). That’s where it’s been rejected multiple times. In short: Stay above $46 → trend continues, bounce potential. Lose $46 → likely drop to mid-$40s or even $40 before finding footing. Break $54 → confirmation of next leg higher toward $60+.
NYSE:HIMSLong
by Grit4trades
HIMS LongReasoning: Virtual Contraction Pattern! Remember: Every long-term investment alert can also be played as a swing trade. Long-Term Investors (3-12 Month Holds) Entry: Full position on breakout Profit Taking: Sell 1/4 to 1/5 at Goal 1 Exit Signal: Close below 20-day EMA (your trend guide) or 50EMA Why: Strong moves are hard to time at the top, but the 20EMA acts as a reliable trend filter Swing Traders (2-6 Week Holds) Entry: Full position on breakout Profit Taking: Sell 1/3 at Goal 1 Final Exit: Remainder at Goal 2
NYSE:HIMSLong
by vssebuyungo
HIMS OCT 2025HIMS — Price is holding above the 50–45 support and the rising trendline after repeated mid-range rejections. Supply/distribution remains inside the upper box (gap overhead). Bids show absorption in 50–45; 40 is the last institutional support before the weekly base at 25–20. • Target up: 58–60 (gap fill), stretch 65–70 under major supply. • Target down: 50 → 45 → 40; loss of 40 opens 25–20 weekly support. #HIMS #globaltrade #investment #investing #stockmarket #wealth #realestate #markets #economy #finance #money #forex #trading #price #business #currency #blockchain #crypto #cryptocurrency #airdrop #btc #ethereum #ico #altcoin #cryptonews #Bitcoin #ipo
NYSE:HIMSLong
by TWMMPRO
Will Hims & Hers Health Sustain Its Bullish Growth Trajectory?Current Price: $52.54 Direction: LONG Targets: - T1 = $55.20 - T2 = $58.50 Stop Levels: - S1 = $50.50 - S2 = $49.00 **Wisdom of Professional Traders:** This analysis synthesizes insights from thousands of professional traders and market experts, leveraging collective intelligence to identify high-probability trade setups. The wisdom of crowds principle suggests that aggregated market perspectives from seasoned professionals often outperform individual forecasts. Traders have identified Hims & Hers Health as a high-growth opportunity, emphasizing consistent quarterly performance and strong retail demand for healthcare solutions in a rapidly evolving industry. **Key Insights:** Hims & Hers Health has emerged as a leader in the telehealth market, benefiting from consumer-focused strategies and robust product offerings. Analysts widely credit the company’s success to its ability to address gaps in traditional healthcare with affordable, convenient solutions. Its subscription-based model is seen as sticky, driving recurring revenues that appeal to institutional investors. The company has aggressively expanded its operations in 2025, tapping into new markets and broadening its product range while maintaining tight cost controls. Key metrics, such as its subscriber growth rate and gross margin improvements, indicate that Hims & Hers is not just growing its top-line revenue but also achieving greater operational efficiency. With the healthcare demands of Gen Z and millennials surging, the company is positioned to capitalize on strong secular trends. **Recent Performance:** Hims & Hers Health has shown resilience in recent quarters, beating Wall Street estimates in Q2 2025 with 28% year-over-year revenue growth and record-breaking net subscriber additions. The stock’s current price reflects a healthy consolidation after rallying from $45 earlier this year. Despite broader market volatility, HIMS has stayed firmly bullish due to its strong fundamentals and sector tailwinds. **Expert Analysis:** Experienced market professionals emphasize Hims & Hers Health’s innovative approach in an increasingly competitive telehealth space. Technical analysis highlights the stock’s bullish breakout above the $50 level, which has now turned into strong support. The RSI, currently at 61, indicates room for further upside without overextended momentum. Moving averages are trending upwards, reflecting bullish sentiment, while trading volumes remain elevated, confirming institutional interest in the equity. Experts also point to management’s proactive initiatives, such as international expansion and partnerships with key retailers, as catalysts for sustained growth. Hims & Hers' ability to balance aggressive growth strategies without compromising profitability has made it a standout performer. Traders are closely watching its upcoming Q3 earnings report as the next potential inflection point for price momentum. **News Impact:** Recent news regarding Hims & Hers Health’s partnership with leading pharmacy chains has added additional credibility to its retail strategy, widening its consumer base and boosting investor confidence. Furthermore, analysts highlight its successful entry into remote mental health services, which is projected to drive incremental revenue for the upcoming quarters. Positive media coverage on its competitive edge in subscription programs has reinforced the stock’s image as a high-growth play. **Trading Recommendation:** With strong fundamentals, sector leadership, and bullish technical indicators, traders should consider going long on HIMS. The stock’s recent movements suggest a clear upward trajectory, supported by robust demand for its products and services. Buy positions should be initiated with a stop-loss at $50.50 (S1) to manage risks effectively, while targeting $55.20 (T1) and $58.50 (T2) for potential upside gains. Upcoming earnings and operational updates may further fuel investor sentiment and drive momentum into 2025. Do you want to save hours every week? Register for the free weekly update in your language!
NYSE:HIMSLong
by CrowdWisdomTrading
$HIMS growth slowdown ahead- NYSE:HIMS is quite overvalued. There's no moat to a business model. - They got a good branding that's all. There are 10-15 other startups selling the same things under different umbrella. - They even stole NYSE:NVO flagship weight loss drugs. These cheap alternatives will risk lives of people and will open plethora of lawsuits. - Growth is slowing down to low 20s which calls for correction in the multiple. - Anyone paying more than 20x will likely suffer from massive losses within an year timeframe. - Fundamentally, Year | 2025 | 2026 | 2027 | 2028 EPS | 0.57 | 0.79 | 1.05 | 1.40 EPS% | 5.76% | 38.31% | 32.59% | 33.25% Giving benefit of doubt and being generous, 30x multiple as a base case. Fair stock value: Year | 2025 | 2026 | 2027 | 2028 Price | $17 | $23 | $31 | $42 - We should visit the $23-26 range somewhere in 2026
NYSE:HIMSShort
by bigbull037
HIMS 1D: time to heal the trend?On the daily chart, Hims & Hers Health is testing a descending trendline, while MA50 and MA200 provide strong support from below. Buyers are clearly in control. The highlighted buy zone sits around $54.40, but the real signal comes only after a confirmed breakout and retest of the trendline. Technically , the targets are set: first stop at $73.23, then $86.64, and if momentum holds, the extension points to $103.69. That would mark a strong continuation of the bullish move. From the fundamental side, the company keeps expanding its product portfolio and growing its presence in telehealth — a sector known for resilience even during market turbulence. The tactical play: wait for the breakout and retest, then ride the bullish wave. Just don’t confuse HIMS with a real doctor - if you ask for a prescription for profits, all you’ll get is a smile.
NYSE:HIMSLong
by TotoshkaTrades
2
$HIMS weekend analysis - 21st September, 2025Last week’s news-driven dip to the 48–49 range turned into a solid buying opportunity - the quick recovery shows it was more noise than substance. With the strong bounce, price looks set to retest the key 62.3 - 64.9 resistance zone, which could be the target for this week. If we get a daily close above that zone and it flips into support, there’s a real shot at new 52-week highs in the short term. On the downside, a close below 50.4 (volume shelf) would break this setup and call for a re-check.
NYSE:HIMSLong
by zaidriaz992
1
Hims long into supplyHims has decided to push the supply as we previously mentioned. We note a breakout of the OBV, which I have been tracking (momentum). As I previously stated, I was looking for a push to 60 again. Volatility has reset, and shorts are being squeezed. I would like to think that 51-ish is the new range, but he likes to surprise in both directions. I believe we push 65$ here in the short term. Volume is rising on the weekly. My plan: I sold shares into this pump in my IRA to focus more on large caps there (AMD). I did swing some new shares on this move. Sell calls into the top of supply at 63, put sells should be safe, as well as 6 mo + calls
NYSE:HIMSLong
by Apollo_21mil